Riera-Leal L et al. [42] and Perm et al. [43] performed immunostaining for CEA and EMA, revealing that EMA showed a higher positivity rate than CEA in the analysis of PC tumors. This evidence concerns the gene CEACAM5 and pachyonychia congenita.